Latest radiation therapy Stories
In a retrospective study recently online by The Oncologist, Jason Faris, M.D., Medical Oncologist at the Massachusetts General Hospital Cancer Center in Boston, and colleagues described their institutional experience with the FOLFIRINOX treatment protocol in patients with locally advanced pancreatic cancer. Durham, NC (PRWEB) May 08, 2013 Treatment with neoadjuvant 5-FU, oxaliplatin, irinotecan, and leucovorin (FOLFIRINOX) followed by chemoradiation shows substantial activity in patients...
Because pregnant women and cancer patients share common safety concerns and experience many of the same skin conditions, the topical skin care products they desire are very similar. Pretty Mommies along with truespa Skin Care Center discuss the recent trend of maternity skin care being used by oncology patients. Orlando, FL (PRWEB) May 09, 2013 It is no surprise that pregnancy and nursing skin care products are held to a higher standard of safety. This is due to the fact that many...
Guideline provides detailed direction on treatment options for prostate cancer patients SAN DIEGO, May 7, 2013 /PRNewswire/ -- The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence. The 81-page document represents an intensive collaboration among experts in the radiation...
Cianna Medical, Inc.: Researchers from 12 sites report favorably low recurrence rates and minimal toxicities. CHICAGO (PRWEB) May 02, 2013 Strut-based breast brachytherapy – a form of radiation therapy for early-stage breast cancer – has been shown to be a well-tolerated, effective treatment, according to a scientific poster presentation at the 2013 annual meeting of the American Society of Breast Surgeons (ASBrS) in Chicago, May 1-5, 2013. The...
Findings Demonstrate Utility of Oncotype DX® to Guide Radiation Treatment Decision for DCIS Patients and Support Expanded Access and Reimbursement REDWOOD CITY, Calif. and PHILADELPHIA, May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) and the ECOG-ACRIN Cancer Research Group announced today that the Journal of the National Cancer Institute (JNCI) published positive results from their clinical validation study of the Oncotype DX® DCIS Score in patients with ductal...
Technology advancements paired with new tools allow neurosurgeons to resect deep brain tumors once deemed inoperable CHICAGO, May 1, 2013 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) is among the first hospitals in the country to offer a new minimally invasive surgery for patients with deep subcortical tumors and cysts. The new approach integrates several advancements in neurosurgery, allowing doctors to...
'This study confirms that VEGF is not a path forward to tackling this disease' The well-studied protein VEGF does not appear to have any prognostic or predictive value for men with locally advanced prostate cancer, researchers from the Department of Radiation Oncology at Thomas Jefferson University Hospital and other institutions found in a retrospective study published online April 25 in the journal BMC Radiation Oncology. VEGF, or vascular endothelial growth factor, induces blood...
128 Patient MuGard Study Underscores the Powerful Clinical Impact MuGard Provides Cancer Patients Suffering with Oral Mucositis DALLAS and NEW YORK, April 29, 2013 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), an emerging biopharmaceutical company, announced that Carrie Daly, MS, RN, APN, AOCN of Rush University Medical Center presented data from a MuGard study, performed by the Institution, at last week's Oncology Nursing Society Annual Congress in Washington, DC....
Oncology Departments in North Middlesex and Poole Acquire Final Two TrueBeam Systems Made Available Under NHS Supply Chain Initiative CRAWLEY, U.K., April 29, 2013 /PRNewswire/ -- Hospitals in London and Dorset have acquired the final two of ten advanced Varian Medical Systems (NYSE: VAR) radiotherapy treatment machines offered as part of an innovative government program to roll out the most modern cancer treatments for patients in the UK's public hospitals. North Middlesex...
Dennis R. HIll MD, Radiation Oncologist at the Alta Bates Summit Medical Center in Oakland, CA discusses the latest in prostate cancer treatments. Oakland, CA (PRWEB) April 27, 2013 Dennis R. Hill MD, Radiation Oncologist at the Alta Bates Summit Medical Center in Oakland, CA, who specializes in HDR Prostate Brachytherapy, a prostate cancer treatment option with less risk of side effects than external beam radiation methods, discusses a newer treatment now available, called the Calypso...
